smoking cessation
The National Cancer Institute (NCI) has awarded Chrono Therapeutics a Small Business Innovation Research (SBIR) grant of up to $2.
Chrono Therapeutics, a Hayward, California-based company working on a new wearable for smoking cessation and drug delivery, has raised $32 million in its first round of funding.
Around 11 percent of smokers who participated in a texting-based smoking cessation intervention program were able to abstain from using cigarettes six months after the start of the program, while only 5 percent of smokers in the control group were able to do so, according to a study of 503 people published in the American Journal of Preventive Medicine.